chrisvoncsefalvay/vaers-outcomes huggingface dataset:
*spasm/pain to back of neck at top of spine, center - began @ 6:00 pm 05/03 stopped by am 05/04. *aching/spasm across scapulae - began during the night after going to bed @ 8:00pm, stopped by am 05/05 *inflammation down both arms to hands - began during the night @ 8:00pm, stopped by am 05/04 *chills - began during the night @8:00pm, stopped by 2:00pm 05/04 *nausea, muscle weakness overall, excessive sweating, ringing in ears while attempting to evacuate bowels - began @ 8:00am 05/04 stopped appx. one half hour later *excessive sleepiness - began 10:00am 05/04, ongoing as of 05/05  *stayed out of work 05/04 through 05/05
Patient fully vaccinated and died due to covid related causes.  Patient has a previous medical history of ESRD, anemia of chronic disease, HTN, osteopenia and sarcoidosis. Patient presented to ER on 09/06/2021 with complaints of increasing SOB with productive cough, headache, and occasional nausea. Patient was found to be hypoxic with O2 in 60s on arrival and had to be placed on Bipap. Patient expired on 09/17/2021.
Tingling in finger tips and tingling in toes after the second dose early the next morning. I still have it.
Narrative:  unrelated asthma history was triggered in clinic shortly after vaccine was administered monitored for 15 additional minutes after symptoms was self treated by her personal inhaler reported symptoms alleviated on their own and was released from clinic
Swelling at injection site - waited with patient. Swelling subsided quickly - bruised the next day (felt hard). Hard at the injection site.
Muscle aches; Chills; Night Sweats; Light headed; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of NIGHT SWEATS (Night Sweats), DIZZINESS (Light headed), MYALGIA (Muscle aches), CHILLS (Chills) and VACCINATION SITE PAIN (pain at the injection site) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE and TRAZODONE for an unknown indication.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced DIZZINESS (Light headed) and VACCINATION SITE PAIN (pain at the injection site). On 13-Apr-2021, the patient experienced NIGHT SWEATS (Night Sweats) and CHILLS (Chills). On 15-Apr-2021, the patient experienced MYALGIA (Muscle aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 15-Mar-2021, DIZZINESS (Light headed) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown. On 14-Apr-2021, NIGHT SWEATS (Night Sweats) had resolved. At the time of the report, MYALGIA (Muscle aches) and CHILLS (Chills) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
About 10 minutes after receiving vaccination, patient started experiencing cold sweats and he felt like we was about to pass out. I took him into the clinic room and allowed him to lay down and began to fan him down for him to cool off. After 1-2 minutes, we put him on his back and elevated his feet. While he was laying down, I checked his blood pressure and it was low. I let him lay down for 5 more minutes and he started to feel much better and was cooled down. I slowly got him up and allowed him to sit and checked his blood pressure again. The blood pressure began to normalize. After 5 more minutes, I told him to get up and slowly walk to another chair in the room. Once he was rested there for about 5 minutes, I checked his blood pressure a 3rd time in the opposite arm and it was normal. He no longer felt the light headed feeling and was cooled off. The patient's partner then informed me that he has a fear of needles and the last time he received a vaccination about 7 years ago, the same reaction happened.
Hyaluronic Acid Lip Filler with pronounced swelling. Filler had been injected approximately 2 months prior to vaccination
Grandmother states 1 hour after immunizations child went to itching around ears and it moved on down trunk area and he broke out.  Went to hospital and was given Benadryl.
Patient experienced redness, swelling, itching, warm to touch. Patient was a lot sore whether or not it was the vaccine or the bandaid that cause reaction. Bandaid was non latex.
Patient here today to get her second covid vaccine.  When answering the questions, patient stated that she did have a localized site reaction after the first vaccine.   Patient had swelling, redness and itchiness at the site of injection.  Patient stated that after a few days the redness and swelling disappeared   Blood pressure cuff was changed to a larger cuff and blood pressure was 175/89.  Per PCP patient ok to go home but to monitor her blood pressure and if it was still elevated she needed to contact her primary care doctor.   Patient wished to go to her primary doctor who was on the third floor so that she could check her blood pressure.   Patient ambulated from room without difficultyt had tingling
Painful, red injection site. Malaise, fever, body/muscle ache, mild nausea.
eyelids were swollen; eyes were all red; felt like sand in the left eye; little bruise on the injection site; numbness on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (little bruise on the injection site), INJECTION SITE HYPOAESTHESIA (numbness on the injection site), OCULAR HYPERAEMIA (eyes were all red), OCULAR DISCOMFORT (felt like sand in the left eye) and SWELLING OF EYELID (eyelids were swollen) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included INSULIN INJECTION, LISINOPRIL, PRAVASTATIN and OMEPRAZOLE for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE BRUISING (little bruise on the injection site) and INJECTION SITE HYPOAESTHESIA (numbness on the injection site). On 02-Feb-2021, the patient experienced OCULAR HYPERAEMIA (eyes were all red) and OCULAR DISCOMFORT (felt like sand in the left eye). On an unknown date, the patient experienced SWELLING OF EYELID (eyelids were swollen). On 03-Feb-2021, VACCINATION SITE BRUISING (little bruise on the injection site), OCULAR HYPERAEMIA (eyes were all red), OCULAR DISCOMFORT (felt like sand in the left eye) and SWELLING OF EYELID (eyelids were swollen) had resolved. At the time of the report, INJECTION SITE HYPOAESTHESIA (numbness on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This spontaneous report as received from a physician refers to a female patient of unknown age. The patient was vaccinated with dose 1 GARDASIL in March 2012 (dose, site of administration and lot # not reported). No adverse events reported. Additional information has been requested.
Chills and body aches that night.  Arm that vaccine was injected was sore.  Armpit of the arm that was injected was sore.  Developed swollen lymph node above clavicle on side of injection.
the second dose was the worse pain; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (the patient had shingles twice). Previously administered products included shingles vaccine (1st dose received on unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     Additional Information: GSK receipt date: 22-JUL-2022 Reporter's comments: This case was reported by the patient via interactive digital media. The patient asked that even if we had shingles get vaccine because the  patient had them twice. The patient experienced worst pain after receiving 2nd dose of shingles vaccine.
mild symptoms due to Covid-19 after having first dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (mild symptoms due to Covid-19 after having first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 28-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jun-2021, the patient experienced COVID-19 (mild symptoms due to Covid-19 after having first dose). On 16-Jun-2021, COVID-19 (mild symptoms due to Covid-19 after having first dose) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Jun-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications information was reported. On 25-Jun-2021, the patient's second dose was scheduled. No treatment medications were provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Event outcome updated, event stop date added
The vaccine was initially stored in the refrigerator on 11-Jan-2022 and administered on 09-Mar-2022; First dose administered on 27-Jan-2022 and second dose administered on 09-Mar-2022; inadvertently administered expired dose of the Moderna COVID-19 vaccine (dose administered more than 30 days after storage in fridge); This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (inadvertently administered expired dose of the Moderna COVID-19 vaccine (dose administered more than 30 days after storage in fridge)), PRODUCT STORAGE ERROR (The vaccine was initially stored in the refrigerator on 11-Jan-2022 and administered on 09-Mar-2022) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose administered on 27-Jan-2022 and second dose administered on 09-Mar-2022) in an 81-year-old female patient who received mRNA-1273 (Spikevax) (batch nos. 084J21A and 084J21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 09-Mar-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (inadvertently administered expired dose of the Moderna COVID-19 vaccine (dose administered more than 30 days after storage in fridge)) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose administered on 27-Jan-2022 and second dose administered on 09-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine was initially stored in the refrigerator on 11-Jan-2022 and administered on 09-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (inadvertently administered expired dose of the Moderna COVID-19 vaccine (dose administered more than 30 days after storage in fridge)), PRODUCT STORAGE ERROR (The vaccine was initially stored in the refrigerator on 11-Jan-2022 and administered on 09-Mar-2022) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose administered on 27-Jan-2022 and second dose administered on 09-Mar-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.   The reporter reported that the staff were not dating the boxes of vaccine when placing them in the fridge for storage. This lot number (084J21A) was received and placed in the fridge on 11-Jan-2022, which means that all doses administered more than 30 days after 11-Jan-2022 and were not in accordance with a Regulatory Authority. The vaccine in question did not experience any temperature excursions.  The patient had not reported any adverse reaction.  No treatment information was provided by the reporter.
Swollen Feet; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen Feet) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen Feet). At the time of the report, PERIPHERAL SWELLING (Swollen Feet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment information was provided.
dose administered past the expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose administered past the expiry date) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose administered past the expiry date). On 01-Nov-2021, EXPIRED PRODUCT ADMINISTERED (dose administered past the expiry date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 08-Nov-2021: Follow-up received contains Significant information. Patient details updated. Product start date, expiry date were added.
Pain/swelling at injection site, headache, joint pain, all over body pain, fatigue, nausea, dizziness
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Mar2021 as dose 1, single (Lot number: ER8733), on 22Apr2021 as dose 2, single (Lot number: EW0175) and on 12Nov2021 as dose 3 (booster), single (Lot number: EW0217) at the age of 39 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical information includes the patient was taking other medications/products within 2 weeks of starting COVID-19 treatment. The patient was treated with antiviral treatment from 10Jul2022 to 14Jul2022 for treatment of COVID-19.  No follow-up attempts are possible. No further information is expected.
Participant experienced swelling after vaccination/no EPI administered. Participant took Benadryl, which did not help, so participant went to hospital.
PATIENT RECEIVED VACCINATION. APPROXMATELY 10 MINS LATER THROAT FELT "STRANGE". BECAME HOT AND HAD MINOR CHEST TIGHTNESS. VITAL SIGNS REMAINED STABLE. OBSERVED FOR ADDITIONAL 30 MINS. LEFT ON OWN ACCORD WITH RESOLVED SYMPTOMS.
Severe chest pain; Elevated heart rate.; Dizziness; Fever; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 53-years-old male patient received a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8729) via an unspecified route of administration in left arm on 30Apr2021 at 13:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included blood clots and penicillin allergy. Concomitant medications included doxycycline (ORACEA) for an unknown indication from an unknown duration. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8729) via an unspecified route of administration in left arm on 08Apr2021 at 15:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Apr2021 (at 02:00 as reported), the patient had experienced severe chest pain, elevated heart rate, dizziness, fever and body aches. On 30Apr2021, the patient underwent Heart rate and the result was Elevated. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events severe chest pain, elevated heart rate, dizziness, fever and body aches was recovered on unknown date.  No follow-up attempts are needed. No further information is expected.
Initial report was received 31 August 2011 from a health care professional. A 50-year-old male patient had received a left deltoid injection of ADACEL, sanofi pasteur Inc lot number U4090AC (corresponding sanofi pasteur Ltd. lot number C3961) on 23 August 2011 and the next day he called the physician's office to report a sore arm with major swelling of the injection site and upper arm. He had no reported concurrent illness. Past medical history was not reported and he had no known allergies. Concomitant medications consisted of COREG DR, LIPITOR, AMBIEN, NARCO, Baby ASA and Vitamins. Relevant diagnostic test/laboratory data and the event outcome were unknown at the time of the report. Follow-up information was received on 17 October 2011 from a health care professional. The patient had received ADACEL intramuscularly (route previously not reported). Onset date for the patient's events was 23 August 2011 (previously not reported). No further information was available at the time of the report. The patient's outcome was reported as recovered "7-8 days". Documents held by sender: None.
Child after getting pediatric Pfizer fell forward staff saw parents trying to wake patient up. hild stiffened then woke up alert staff saw patients eyes roll back. Child sitting in chair awake and alert but anxios us. Mom was soothing the child and we were trying to keep her awake . paramedics arrived checked the child they were ok and sed the child home.
FATIGUE, FEVERISH, CHILLS, HEADACHE, COUGH, BODY ACHES, SORE THROAT DEVELOPED 4 HOURS AFTER INJECTION.  RESOLVED OTHER THAN FATIGUE  AND ACHINESS AS OF 12/8/2021 (4 DAYS POST VACCINATION)
This is a spontaneous report received from a contactable consumer (patient). A patient of unspecified, age and gender, received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# not reported), via an unspecified route of administration, on an unspecified date, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. On an unspecified date, patient reported their heart felt like it was beating faster (pounding); and had shortness of breath. Patient reported, about two weeks ago, they got the shot of the Pfizer vaccine shot. It was the first dose. About 24 hours later, their heart started beating faster and pounding. They had shortness of breath. Patient was supposed to get a next Pfizer shot next Wednesday. The outcome of events: unknown. Information on lot/batch number requested.
For 3 to 4 days I've been feeling itchy from the inside. I am allergic to shell fish and it's the same feeling I get when I eat shell fish. I've been taking Benadryl. Not sure if this is a side effect but I haven't eaten anything to make me feel this way.
Information has been received from a nurse practitioner concerning he 4 year old son with asthma, dermatitis atopic, cow's milk allergy, egg allergy, peanut allergy, allergic reaction to cats, dogs, tree, grass, weeds and mold who on approximately 25-OCT-2006, at the age of 12 months was vaccinated with the first dose of MMR II vaccine. On 02-NOV-2009 afternoon, the patient was vaccinated with the second dose of MMR II vaccine in the upper arm. Secondary suspect vaccination included a dose of AFLURIA (MSD) 2 weeks prior to getting the MMR II vaccine. Concomitant vaccination administered on 02-NOV-2009 included 3 unspecified vaccines. The reporter did not recall the name of the vaccines, but stated that the vaccinations were appropriate for 4 year old age group. 2 vaccinations were given in each arm. Other concomitant therapies included montelukast sodium (MSD), 1 puff of FLOVENT, multivitamin with sodium FLOVENT and PERIACTIN. On 02-NOV-2009, the patient was monitored for approximately 15 minutes post vaccination and then went home. Approximately 45 minutes later at home, the patient's face and ears were red and itchy. The patient developed congestive cough, headache and stomachache. unspecified medical attention was sought. There were no laboratory diagnostic studies performed. the patient was treated with 18.75mg of BENADRYL and 2 puffs of albuterol inhaler. Forty minutes later, the patient had relieved from the reaction. In the evening at 9PM, CLARITIN, 5mg was also given to the patient. By the next morning, the patient fully recovered. The reporter wondered if the vaccination of AFLURIA (MSD) may have contributed to the reaction. Since the patient did not have this type of reaction after the first dose of MMR II vaccine. Follow-up information has been received from a physician concerning a patient with allergic reactions to egg, milk and peanuts and with no illness at the time of vaccination who on 02-NOV-2009 at approximately 3:00PM the patient was vaccinated with the second dose of MMR II vaccine (lot# 664889/0872Y) (rHA) in her right arm. On 02-NOV-2009 at 4:00PM, the patient developed face swelling and itching. The patient did nor seek any medical attention. The patient was given BENADRYL and recovered on 02-NOV-2009. Additional information is not expected.